Insulin glulisine is a rapid-acting modified form of medical insulin that differs from human insulin in that the amino acid asparagine at position B3 is...
6 KB (468 words) - 15:42, 20 May 2024
Insulin aspart, sold under the brand name NovoLog, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. It is...
24 KB (1,890 words) - 05:07, 13 April 2024
acting insulin. It is approved for use in CSII pumps and Flexpen, Novopen delivery devices for subcutaneous injection. Glulisine is rapid acting insulin analog...
22 KB (2,828 words) - 19:32, 20 December 2023
Garg SK (2007). "Combining insulins for optimal blood glucose control in type I and 2 diabetes: focus on insulin glulisine". Vascular Health and Risk...
121 KB (13,799 words) - 06:42, 1 July 2024
Diabetes medication (redirect from Insulin mimetic)
rapid-acting insulins (peak at ~1 hour) are: Insulin lispro (Humalog) Insulin aspart (Novolog) Insulin glulisine (Apidra) Examples of short-acting insulins (peak...
50 KB (5,221 words) - 07:50, 11 July 2024
Aventis Lantus insulin "glargine" analogue approved for clinical use in the US and the EU. 2004 Sanofi Aventis Apidra insulin "glulisine" insulin analogue approved...
110 KB (11,398 words) - 13:41, 20 July 2024
Insulin icodec, sold under the brand name Awiqli, is a medication used for the treatment of diabetes to improve glycemic control. It is an ultralong-acting...
8 KB (507 words) - 03:48, 24 June 2024
being unable to produce insulin and one of the actions of dulaglutide is to stimulate functioning islet cells to produce more insulin. Dulaglutide can be...
16 KB (1,511 words) - 23:59, 19 July 2024
Insulin glargine sold under the brand name Lantus among others is a long-acting modified form of medical insulin, used in the management of type I and...
20 KB (1,622 words) - 15:05, 11 April 2024
in conjunction with insulin therapy.[citation needed] Mainly used in Type II diabetes, metformin is considered to increase insulin sensitivity in vivo...
9 KB (910 words) - 08:39, 14 July 2024